MARKET

AKYA

AKYA

Akoya Biosciences, Inc.
NASDAQ
1.170
-0.050
-4.10%
After Hours: 1.170 0 0.00% 16:05 04/04 EDT
OPEN
1.190
PREV CLOSE
1.220
HIGH
1.200
LOW
1.070
VOLUME
161.90K
TURNOVER
--
52 WEEK HIGH
4.690
52 WEEK LOW
1.070
MARKET CAP
58.29M
P/E (TTM)
-1.0444
1D
5D
1M
3M
1Y
5Y
1D
AKOYA BIOSCIENCES INC -PURSUANT TO SECURITIES PURCHASE AGREEMENT, CO TO ISSUE CONVERTIBLE NOTES UP TO $30 MILLION - SEC FILING
Reuters · 16h ago
AKOYA BIOSCIENCES - ON APRIL 2, ENTERED SECURITIES PURCHASE AGREEMENT WITH QUANTERIX CORPORATION
Reuters · 16h ago
Quanterix: Still Many, Many Questions
Seeking Alpha · 2d ago
Akoya Biosciences And Team SAMBAI Select PhenoCycler-Fusion As Foundational Spatial Proteomics Technology For Large-Scale Study To Address Cancer Inequities
Benzinga · 2d ago
Akoya Biosciences, Team SAMBAI announce selection of PhenoCycler-Fusion
TipRanks · 2d ago
Weekly Report: what happened at AKYA last week (0324-0328)?
Weekly Report · 4d ago
This Waters Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Benzinga · 03/26 13:57
Tikvah intends to vote against Quanterix’s proposed merger with Akoya
TipRanks · 03/25 19:34
More
About AKYA
More
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Recently
Symbol
Price
%Change

Webull offers Akoya Biosciences Inc stock information, including NASDAQ: AKYA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, AKYA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading AKYA stock methods without spending real money on the virtual paper trading platform.